Skip to main content
Log in

An Investigation into the Influence of Process Parameters and Formulation Variables on Compaction Properties of Liquisolid Systems

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

Liquisolid technology, as a promising approach for bioavailability enhancement, has received increasing attention in recent years. However, literature reports addressing the challenges for its industrial application, particularly those related to compaction behavior of liquisolid systems, are scarce. The aim of this study was to investigate the influence of process parameters and formulation variables on the flowability, wetting, and compaction properties of the liquisolid systems prepared in a fluid bed processor. The experiments with microcrystalline cellulose, as a carrier, were performed according to 23 full factorial design. The effects of liquid content, spray air pressure, and liquid feed rate on the properties of liquisolid systems were investigated. Liquisolid admixtures with microcrystalline cellulose were compared with those prepared with novel carriers, Fujicalin® and Neusilin® US2. “Out-die” Heckel, modified Walker, and Kuentz-Leuenberger models were used to analyze the compressibility of liquisolid admixtures. The results obtained showed that an increase in liquid content (in the range of 10 to 15%) led to a decrease in flowability of liquisolid admixtures with microcrystalline cellulose, as well as more pronounced influence of spraying conditions. On the other hand, higher liquid content led to higher compressibility. Fujicalin® and Neusilin® US2 liquisolid admixtures were found to have superior flowability and compressibility in comparison with those with microcrystalline cellulose, despite the considerably higher liquid load (50–55% liquid content in Neusilin® US2 compacts). Acceptable compactibility of the investigated liquisolid systems was observed. The fluid bed processor was shown to be suitable equipment for production of liquisolid systems, but with careful adjustment of process parameters.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Spireas S, Bolton SM. Liquisolid systems and methods for preparing same. United States patent 5,800,834, 1998.

  2. Spireas S. Liquisolid systems and methods for preparing same. United States patent 6,423,339 B1, 2002.

  3. Javadzadeh Y, Siahi MR, Asnaashari S, Nokhodchi A. An investigation of physicochemical properties of piroxicam liquisolid compacts. Pharm Dev Technol. 2007;12:337–43.

    CAS  Google Scholar 

  4. Hentzschel CM, Sakmann A, Leopold CS. Suitability of various excipients as carrier and coating materials for liquisolid compacts. Drug Dev Ind Pharm. 2011;37(10):1200–7.

    CAS  Google Scholar 

  5. Vranikova B, Gajdziok J, Vetchy D. Determination of flowable liquid retention potential of aluminometasilicate carrier for liquisolid systems preparation. Pharm Dev Technol. 2015;20:839–44.

    CAS  Google Scholar 

  6. Jadhav NR, Irny PV, Patil US. Solid state behavior of progesterone and its release from Neusilin US2 based liquisolid compacts. J Drug Deliv Sci Technol. 2017;38:97–106.

    CAS  Google Scholar 

  7. Vranikova B, Gajdziok J. Evaluation of sorptive properties of various carriers and coating materials for liquisolid systems. Acta Pol Pharm Drug Res. 2015;72(3):539–49.

    CAS  Google Scholar 

  8. Nokhodchi A, Hentzschel CM, Leopold CS. Drug release from liquisolid systems: speed it up, slow it down. Expert Opin Drug Deliv. 2011;8(2):191–205.

    CAS  Google Scholar 

  9. Elkadi S, Elsamaligy S, Al-Suwayeh S, Mahmoud H. The development of self-nanoemulsifying liquisolid tablets to improve the dissolution of simvastatin. AAPS PharmSciTech. 2017;18(7):2586–97.

    CAS  Google Scholar 

  10. Pezzini BR, Beringhs AO, Ferraz HG, Silva MAS, Stulzer HK, Sonaglio D. Liquisolid technology applied to pellets: evaluation of the feasibility and dissolution performance using felodipine as a model drug. Chem Eng Res Des. 2016;110:62–9.

    CAS  Google Scholar 

  11. Gong W, Wang Y, Sun L, Yang J, Shan L, Yang M, et al. Development of itraconazole liquisolid compact: effect of polyvinylpyrrolidone on the dissolution properties. Curr Drug Deliv. 2016;13(3):452–61.

    CAS  Google Scholar 

  12. Javadzadeh Y, Navimipour BJ, Nokhodchi A. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm. 2007;341:26–34.

    CAS  Google Scholar 

  13. Tayel SA, Soliman II, Louis D. Improvement of dissolution properties of carbamazepine through application of the liquisolid tablet technique. Eur J Pharm Biopharm. 2008;69:342–7.

    CAS  Google Scholar 

  14. Vittal GV, Deveswaran R, Bharath S, Basavaraj BV, Madhavan V. Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design. Int J Pharm Investig. 2012;2(3):150–6.

    Google Scholar 

  15. Vranikova B, Gajdziok J, Vetchy D. Modern evaluation of liquisolid systems with varying amounts of liquid phase prepared using two different methods. Biomed Res Int. 2015;2015:608435. https://doi.org/10.1155/2015/608435.

    Article  CAS  Google Scholar 

  16. Hentzschel CM, Alnaief M, Smirnova I, Sakmann A, Leopold CS. Enhancement of griseofulvin release from liquisolid compacts. Eur J Pharm Biopharm. 2012;80:130–5.

    CAS  Google Scholar 

  17. Tiong N, Elkordy AA. Effects of liquisolid formulations on dissolution of naproxen. Eur J Pharm Biopharm. 2009;73:373–84.

    CAS  Google Scholar 

  18. Spireas S, Wang T, Grover R. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts. Drug Dev Ind Pharm. 1999;25(2):163–8.

    CAS  Google Scholar 

  19. Bolko Seljak K, German Ilić I, Gašperlin M, Zvonar PA. Self-microemulsifying tablets prepared by direct compression for improved resveratrol delivery. Int J Pharm. 2018;548:263–75.

    CAS  Google Scholar 

  20. Komala DR, Janga KY, Jukanti R, Bandary S. Competence of raloxifene hydrochloride loaded liquisolid compacts for improved dissolution and intestinal permeation. J Drug Deliv Sci Technol. 2015;30:232–41.

    CAS  Google Scholar 

  21. Badawy МА, Kamel АО, Sammour ОА. Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study. Drug Deliv. 2016;23(3):818–27.

    Google Scholar 

  22. Khaled KA, Asiri YA, El-Sayed YM. In vivo evaluation of hydrochlorothiazide liquisolid tablets in beagle dogs. Int J Pharm. 2001;222:1–6.

    CAS  Google Scholar 

  23. Khames A. Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique. Drug Deliv. 2017;24(1):328–38.

    CAS  Google Scholar 

  24. Khames A. Formulation and characterization of eplerenone nanoemulsion liquisolids, an oral delivery system with higher release rate and improved bioavailability. Pharmaceutics. 2019;11(1):40.

    CAS  Google Scholar 

  25. Jhaveri M, Nair AB, Shah J, Jacob S, Patel V, Mehta T. Improvement of oral bioavailability of carvedilol by liquisolid compact: optimization and pharmacokinetic study. Drug Deliv Transl Res. 2020;10:975–85. https://doi.org/10.1007/s13346-020-00734-3.

    Article  CAS  Google Scholar 

  26. Sheta NM, Elfeky YA, Boshra SA. Cardioprotective efficacy of silymarin liquisolid in isoproterenol prompted myocardial infarction in rats. AAPS PharmSciTech. 2020;21:81. https://doi.org/10.1208/s12249-019-1609-3.

    Article  CAS  Google Scholar 

  27. Patel K, Doddapaneni R, Patki M, Sekar V, Bagde A, Singh M. Erlotinib-valproic acid liquisolid formulation: evaluating oral bioavailability and cytotoxicity in erlotinib-resistant non-small cell lung cancer cells. AAPS PharmSciTech. 2019;20:135. https://doi.org/10.1208/s12249-019-1332-0.

    Article  CAS  Google Scholar 

  28. Jyoti J, Anandhakrishnan NK, Singh SK, Kumar B, Gulati M, Gowthamarajan K, et al. A three-pronged formulation approach to improve oral bioavailability and therapeutic efficacy of two lipophilic drugs with gastric lability. Drug Deliv Transl Res. 2019;9:848–65.

    CAS  Google Scholar 

  29. Basalious EB, El-Sebaie W, El-Gazayerly O. Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis: development, optimization and in vitro/in vivo studies. Pharm Dev Technol. 2013;18(2):407–16.

    CAS  Google Scholar 

  30. Moqbel HA, ElMeshad AN, El-Nabarawi MA. Comparative study of different approaches for preparation of chlorzoxazone orodispersible tablets. Drug Dev Ind Pharm. 2017;43(5):742–50.

    CAS  Google Scholar 

  31. Javadzadeh Y, Musaalrezaei L, Nokhodchi A. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices. Int J Pharm. 2008;362:102–8.

    CAS  Google Scholar 

  32. Nokhodchi A, Aliakbar R, Desai S, Javadzadeh Y. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release. Colloids Surf B: Biointerfaces. 2010;79:262–9.

    CAS  Google Scholar 

  33. Kumar DS, Aparna C, Srinivas P. Immediate and mucoadhesive sustained release compacts of itraconazole using liquisolid technology. Int J Pharm Technol. 2015;7(3):9513–33.

    CAS  Google Scholar 

  34. Anzilaggo D, Beringhs AO, Pezzini BR, Sonaglioa D, Stulzera HK. Liquisolid systems: understanding the impact of drug state (solution or dispersion), nonvolatile solvent and coating material on simvastatin apparent aqueous solubility and flowability. Colloids Surf B: Biointerfaces. 2019;175:36–43.

    CAS  Google Scholar 

  35. Baranauskaite J, Kopustinskiene DM, Masteikova R, Gajdziok J, Baranauskas A, Bernatoniene J. Effect of liquid vehicles on the enhancement of rosmarinic acid and carvacrol release from oregano extract liquisolid compacts. Colloids Surf A. 2018;539:280–90.

    CAS  Google Scholar 

  36. Barmpalexis P, Grypioti A, Eleftheriadis GK, Fatouros DG. Development of a new aprepitant liquisolid formulation with the aid of artificial neural networks and genetic programming. AAPS PharmSciTech. 2018;19(2):741–52.

    CAS  Google Scholar 

  37. Fahmy RH, Kassem MA. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2008;69:993–1003.

    CAS  Google Scholar 

  38. Suliman AS, Anderson RJ, Elkordy AA. Preparation of novel optimum liquisolid compacts via incorporating water granulation process to enhance the powder characterizations and dissolution behavior of a poorly soluble drug: Norfloxacin. Powder Technol. 2019;354:259–70.

    Google Scholar 

  39. Jaipakdee N, Limpongsa E, Sripanidkulchai B, Piyachaturawat P. Preparation of Curcuma comosa tablets using liquisolid techniques: in vitro and in vivo evaluation. Int J Pharm. 2018;553:157–68.

    CAS  Google Scholar 

  40. Kurek M, Woyna-Orlewicz K, Khalid MH, Jachowicz R. Optimization of furosemide liquisolid tablets preparation process leading to their mass and size reduction. Acta Pol Pharm Drug Res. 2016;73(5):1325–31.

    CAS  Google Scholar 

  41. Bonthagarala B, Dasari V, Kotra V, Swain S, Beg S. Quality-by-design based development and characterization of pioglitazone loaded liquisolid compact tablets with improved biopharmaceutical attributes. J Drug Deliv Sci Technol. 2019;51:345–55.

    CAS  Google Scholar 

  42. Aleksić I, Stanković N, Cvijić S, Parojčić J. An investigation into the characteristics of liquisolid systems prepared with microcrystalline cellulose and Neusilin® US2 as carriers. Proceedings of the 11th CESPT, 2016 September 22–24, Belgrade, Serbia. Arh Farm. 2016;66(Special Issue):83–4.

    Google Scholar 

  43. Aleksić I, Cvijić S, Parojčić J. An investigation into the characteristics of liquisolid systems prepared with spray dried calcium hydrogen phosphate as carrier. Proceedings of the 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology; 2018 Mar 19–22; Granada, Spain; 250 p.

  44. European Pharmacopoeia 10th edition, Strasbourg: Council of Europe; 2019.

  45. Heckel RW. Density-pressure relationship in powder compaction. Trans Metall Soc AIME. 1961;221:671–5.

    CAS  Google Scholar 

  46. Walker EE. The properties of powder VI: the compressibility of powders. Trans Faraday Soc. 1923;19:73–82.

    Google Scholar 

  47. Sonnergaard JM. Quantification of the compactibility of pharmaceutical powders. Eur J Pharm Biopharm. 2006;63:270–7.

    CAS  Google Scholar 

  48. Kuentz M, Leuenberger H. Pressure susceptibility of polymer tablets as a critical property: a modified Heckel equation. J Pharm Sci. 1999;88:174–9.

    CAS  Google Scholar 

  49. Fell JT, Newton JM. Determination of tablet strength by the diametral-compression test. J Pharm Sci. 1970;59:688–91.

    CAS  Google Scholar 

  50. Armstrong NA, Haines-Nutt RF. Elastic recovery and surface area changes in compacted powder systems. J Pharm Pharmacol. 1972;24:135–6.

    Google Scholar 

  51. Leturia M, Benali M, Lagarde S, Ronga I, Saleh K. Characterization of flow properties of cohesive powders: a comparative study of traditional and new testing methods. Powder Technol. 2014;253:406–23.

    CAS  Google Scholar 

  52. Emery E, Oliver J, Pugsley T, Sharma J, Zhou J. Flowability of moist pharmaceutical powders. Powder Technol. 2009;189:409–15.

    CAS  Google Scholar 

  53. Sandler N, Reiche K, Heinämäki J, Yliruusi J. Effect of moisture on powder flow properties of theophylline. Pharmaceutics. 2010;2:275–90.

    CAS  Google Scholar 

  54. Thalberg K, Lindholm D, Axelsson A. Comparison of different flowability tests for powders for inhalation. Powder Technol. 2004;146:206–13.

    CAS  Google Scholar 

  55. Lu M, Xing H, Yang T, Yu J, Yang Z, Sun Y, et al. Dissolution enhancement of tadalafil by liquisolid technique. Pharm Dev Technol. 2017;22:77–89.

    CAS  Google Scholar 

  56. Ilić I, Govedarica B, Šibanc R, Dreu R, Srčič S. Deformation properties of pharmaceutical excipients determined using an in-die and out-die method. Int J Pharm. 2013;446:6–15.

    Google Scholar 

  57. Grdešič P, Vrečer F, Ilić I. Flow and compaction properties of hypromellose: new directly compressible versus the established grades. Drug Dev Ind Pharm. 2016;42(11):1877–86.

    Google Scholar 

  58. Šantl M, Ilić I, Vrečer F, Baumgartner S. A compressibility and compactibility study of real tableting mixtures: the impact of wet and dry granulation versus direct tableting mixture. Int J Pharm. 2011;414:131–9.

    Google Scholar 

  59. Lamešić D, Planinšek O, German II. Modified equation for particle bonding area and strength with inclusion of powder fragmentation propensity. Eur J Pharm Sci. 2018;121:218–27.

    Google Scholar 

  60. Javadzadeh Y, Shariati H, Movahhed-Danesh E. Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts. Drug Dev Ind Pharm. 2009;35:243–51.

    CAS  Google Scholar 

Download references

Funding

This work was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia (project 451-03-68/2020-14/200161).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ivana Aleksić.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aleksić, I., German Ilić, I., Cvijić, S. et al. An Investigation into the Influence of Process Parameters and Formulation Variables on Compaction Properties of Liquisolid Systems. AAPS PharmSciTech 21, 242 (2020). https://doi.org/10.1208/s12249-020-01781-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/s12249-020-01781-2

KEY WORDS

Navigation